Aquestive Therapeutics, Inc. announced that the company's board of directors confirmed its plan to appoint Santo "Sandy" Costa as chairman, effective as of August 8, 2018. Mr. Costa joined the company’s board in 2015 bringing over 40 years of experience in the pharmaceutical, healthcare and life sciences industries, as well as leadership in the legal sector. Douglas Bratton, chairman since 2004, will continue to serve as a member of the board of directors.